Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients

Transplantation

Volumn 90, Issue 8, 2010, Pages 843-852

  Kulahci, Yalcin ^a,b   Klimczak, Aleksandra ^a   Madajka, Maria ^a   Altuntas, Selman ^a   Siemionow, Maria ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Chimerism; Composite face allotransplantation; Face allograft survival; Vascularized bone marrow transplantation

Indexed keywords

CYCLOSPORIN A;

ANGIOGRAPHY; ANIMAL CELL; ARTICLE; BONE MARROW; CHIMERA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FACIAL TRANSPLANTATION; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; ISOTRANSPLANTATION; LONG TERM CARE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSURGERY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; VASCULARIZATION; ALLOTRANSPLANTATION; ANESTHESIA; ANIMAL; BROWN NORWAY RAT; COMMON CAROTID ARTERY; EDEMA; HAIR DISEASE; HISTOCOMPATIBILITY; JUGULAR VEIN; LEWIS RAT; MANDIBLE; METHODOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TONGUE; TRANSPLANTATION;

ANESTHESIA; ANIMALS; CAROTID ARTERY, COMMON; EDEMA; FACIAL TRANSPLANTATION; FLOW CYTOMETRY; GRAFT SURVIVAL; HAIR DISEASES; JUGULAR VEINS; MANDIBLE; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED BN; RATS, INBRED LEW; TONGUE; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 78349247442     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f28bb0     Document Type: Article

References (42)

1. Latifoglu O, Ayhan S, Atabay K. Total face reconstruction: Skin graft versus free flap. Plast Reconstr Surg 1999; 103: 1076.
2. Kawashima T, Yamada A, Ueda K, et al. Tissue expansion in facial reconstruction. Plast Reconstr Surg 1994; 94: 944.
3. Teot L, Cherenfant E, Otman S, et al. Prefabricated vascularised supra-clavicular flaps for face resurfacing after postburns scarring. Lancet 2000; 355: 1695.
4. Pribaz JJ, Fine N, Orgill DP. Flap prefabricationin the head and neck: A 10-year experience. Plast Reconstr Surg 1999; 103: 808.
5. Cordeiro PG. Frontiersinfree flap reconstructioninthe head and neck. J Surg Oncol 2008; 97: 669.
6. Siemionow M, Bozkurt M, Kulahci Y. Current status of composite tissue allotransplantation. Handchir Mikrochir Plast Chir 2007; 39: 145.
7. Siemionow M, Kulahci Y. Experimental models of composite tissue allograft transplants. Semin Plast Surg 2007; 21: 205.
8. Siemionow M, Papay F, Kulahci Y, et al. Coronal-posterior approach for face/scalp flap harvesting in preparation for face transplantation. J Reconstr Microsurg 2006; 22: 399.
9. Siemionow M, Kulahci Y. Facial transplantation. Semin Plast Surg 2007; 21: 259.
10. Siemionow M, Kulahci Y, Bozkurt M. Composite tissue allotransplan-tation (CTA). Plast Reconstr Surg 2009; 124(6 suppl): e327.
11. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: Early report. Lancet 2006; 368: 203.
12. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2008; 86: 487.
13. Siemionow M, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009; 374: 203.
14. Gozel-Ulusal B, Ulusal AE, Ozmen S, et al. A new composite facial and scalp transplantation model in the rat. Plast Reconstr Surg 2003; 112: 1302.
15. Siemionow M, Gozel-Ulusal B, Ulusal A, et al. Functional tolerance following face transplantation in the rat. Transplantation 2003; 75: 1607.
16. Yazici I, Unal S, Siemionow M. Composite hemiface/calvaria transplantation model in rats. Plast Reconstr Surg 2006; 118: 1321.
17. Yazici I, Carnevale K, Klimczak A, et al. A new rat model of maxilla allotransplantation. Ann Plast Surg 2007; 58: 338.
18. Lukomska B, Durlik M, Cybulska E, et al. Comparative analysis of immu-nological reconstitution induced by vascularized bone marrow versus bone marrow cell transplantation. Transpl Int 1996; 9(suppl 1): S492.
19. Siemionow M, Klimczak A, Unal S, et al. Hematopoietic stem cell en-graftment and seeding permits multi-lymphoid chimerism invascular-ized bone marrow transplants. Am J Transplant 2008; 8: 1163.
20. Talmor M, Steinman RM, Codner MA, et al. Bone marrow-derived chimerism in non-irradiated, cyclosporine-treated rats receiving mi-crovascularized limb transplants: Evidence for donor-derived dendritic cells in recipient lymphoid tissues. Immunology 1995; 86: 448.
21. Siemionow M, Izycki D, Ozer K, et al. Role of thymus in operational tolerance inductioninlimb allograft transplant model.Transplantation 2006; 81: 1568.
22. Kulahci Y, Siemionow M. A new composite hemiface/mandible/ tongue transplantation model in rats. Ann Plast Surg 2010; 64: 114.
23. ButtemeyerR,Jones NF, MinZ,etal. Rejectionofcomponent tissues of limb allografts in rats immunosuppressed with FK-506 and cyclospor-ine. Plast Reconstr Surg 1996; 97: 139.
24. Lee WP, Pan YC, KesmarkyS,etal. Experimental orthotopic transplantation of vascularized skeletal allografts: Functional assessment and long-term survival. Plast Reconstr Surg 1995; 95: 336.
25. Follmar KE, BaccaraniA,Das RR, et al. Osteocutaneous face transplantation. J Plast Reconstr Aesthet Surg 2008; 61: 518.
26. Demir Y, Ozmen S, Klimczak A, et al. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg 2004; 114: 1790.
27. Siemionow M, Demir Y, Mukherjee A, et al. Development and maintenance of donor-specific chimerism in semi-allogenic and fully MHC mismatched facial allograft transplants. Transplantation 2005; 79: 558.
28. Gordon CR, Tai CY, Suzuki H, et al. Review of vascularized bone marrow transplantation: Current status and future clinical applications. Microsurgery 2007; 27: 348.
29. Perry SS, Kim M, Spangrude GJ. Direct effects of cyclosporin A on proliferation of hematopoietic stem and progenitor cells. Cell Transplant 1999; 8: 339.
30. Silverman RP, Banks ND, Detolla LJ, et al. A heterotopic primate model for facial composite tissue transplantation. Ann Plast Surg 2008; 60: 209.
31. Dubernard JM, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007; 357: 2451.
32. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008; 372: 631.
33. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008; 372: 639.
34. Mathers AR, Larregina AT. Professional antigen-presenting cells of the skin. Immunol Res 2006; 36: 127.
35. Bos JD, Zonneveld I, Das PK, et al. The skin immune system (SIS): Distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88: 569.
36. O'Sullivan NL, Skandera CA, Montgomery PC. Lymphocyte lineages at mucosal effector sites: Rat salivary glands. J Immunol 2001; 166: 5522.
37. Starzl TE, Demetris AJ, MuraseN, etal. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
38. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 2003; 17: 1127.
39. Goldschneider I, Gordon LK, Morris RJ. Demonstration of Thy-1 antigen on pluripotent hemopoietic stem cells in the rat. J Exp Med 1978; 148: 1351.
40. Klimczak A, Agaoglu G, Carnevale KA, et al. Applications of bilateral vascularized femoral bone marrow transplantation for chimer-ism induction across MHC barrier: Part II. Ann Plast Surg 2006; 57: 422.
41. MuraseN,Starzl TE, TanabeM, etal. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 1995; 60: 158.
42. Hequet O, Bourgeot JP, Michallet M, et al. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor. Bone Marrow Transplant 2008; 41: 1059.